46TH
ANNUAL
CONGRESS
OF
THE
SAEVA
SKUKUZA
16-‐20
FEBRUARY
2014
55
2.
Théon AP, Wilson WD, Magdesian KG, Pusterla N, Snyder JR, Galuppo LD “Long-term
outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in
equidae: 573 cases (1995–2004)” J Am Vet Med Assoc 2007; 230 (10):1506–1513.
3. Tamzali Y, Borde L, Rols MP, Golzio M, Lyazrhi F, Teissie J “Successful treatment of equine
sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases.” Eq Vet J
2012; 44(2); 214-20.
4. Théon AP, Pascoe JR, Carlson GP, Krag DN “Intratumoral chemotherapy with cisplatin in
oily emulsion in horses.” J Am Vet Med Assoc 1993; 202(2): 261-7.
5. Théon AP, Pascoe JR, Madigan JE, Carlson G, Metzger L “Comparison of intratumoral
administration of cisplatin versus bleomycin for treatment of periocular squamous cell
carcinomas in horses” Am J Vet Res 1997; 58(4): 431-6.
6. Goodrich LR, Semevolous SA “How to Prepare and Inject Cisplatin in Oily Emulsion to Treat
Equine Sarcoids and Squamous Cell Carcinomas” AAEP Proc 2000: 173-175.
7. Hewes CA, Sullins KE “Use of cisplatin-containing biodegradable beads for treatment of
cutaneous neoplasia in equidae: 59 cases (2000-2004)” J Am Vet Med Assoc 2006; 229(10):
1617—1622.
8. Hewes CA “How to use Bioabsorbable Cisplatin Beads to Treat Cutaneous
9. Neoplasia” AAEP Proc 2007: 399-402.
10. Wereszka M, personal communication, August 2013
55